| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Priority Reports |
Departments of 1 Pharmacology and 2 Pathology, Baylor College of Medicine, Houston, Texas
Requests for reprints: Anil K. Jaiswal, Department of Pharmacology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Phone: 713-798-7691; Fax: 713-798-3145; E-mail: ajaiswal{at}bcm.tmc.edu.
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a cytosolic protein that catalyzes metabolic detoxification of quinones and protects cells against redox cycling and oxidative stress. NQO1-null mice deficient in NQO1 protein showed increased sensitivity to 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis. In the present studies, we show that benzo(a)pyrene metabolite benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide and not benzo(a)pyrene quinones contributed to increased benzo(a) pyrene-induced skin tumors in NQO1-null mice. An analysis of untreated skin revealed an altered intracellular redox state due to accumulation of NADH and reduced levels of NAD/NADH in NQO1-null mice as compared with wild-type mice. Treatment with benzo(a)pyrene failed to significantly increase p53 and apoptosis in the skin of NQO1-null mice when compared with wild-type mice. These results led to the conclusion that altered intracellular redox state along with lack of induction of p53 and decreased apoptosis plays a significant role in increased sensitivity of NQO1-null mice to benzo(a)pyrene-induced skin cancer.
Key Words: NQO1 Lack of induction of p53 Chemical Carcinogenesis Prevention Melanoma/skin cancers
This article has been cited by other articles:
![]() |
K. Iskander, R. J. Barrios, and A. K. Jaiswal NRH:Quinone Oxidoreductase 2-Deficient Mice Are Highly Susceptible to Radiation-Induced B-Cell Lymphomas Clin. Cancer Res., March 1, 2009; 15(5): 1534 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iskander, R. J. Barrios, and A. K. Jaiswal Disruption of NAD(P)H:Quinone Oxidoreductase 1 Gene in Mice Leads to Radiation-Induced Myeloproliferative Disease Cancer Res., October 1, 2008; 68(19): 7915 - 7922. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shetty, T. Velusamy, S. Idell, P. Shetty, A. P. Mazar, Y. P. Bhandary, and R. S. Shetty Regulation of Urokinase Receptor Expression by p53: Novel Role in Stabilization of uPAR mRNA Mol. Cell. Biol., August 15, 2007; 27(16): 5607 - 5618. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gong, L. Kole, K. Iskander, and A. K. Jaiswal NRH:Quinone Oxidoreductase 2 and NAD(P)H:Quinone Oxidoreductase 1 Protect Tumor Suppressor p53 against 20S Proteasomal Degradation Leading to Stabilization and Activation of p53 Cancer Res., June 1, 2007; 67(11): 5380 - 5388. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iskander, J. Li, S. Han, B. Zheng, and A. K. Jaiswal NQO1 and NQO2 Regulation of Humoral Immunity and Autoimmunity J. Biol. Chem., October 13, 2006; 281(41): 30917 - 30924. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Ahn, G. Sethi, A. K. Jain, A. K. Jaiswal, and B. B. Aggarwal Genetic Deletion of NAD(P)H:Quinone Oxidoreductase 1 Abrogates Activation of Nuclear Factor-{kappa}B, I{kappa}B{alpha} Kinase, c-Jun N-terminal Kinase, Akt, p38, and p44/42 Mitogen-activated Protein Kinases and Potentiates Apoptosis J. Biol. Chem., July 21, 2006; 281(29): 19798 - 19808. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |